Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
TtheCZELER033Smz